Germline SDHD mutation in familial phaeochromocytoma
Lancet (London, England)
|April 27, 2001
Summary
Genetic mutations in the SDHD gene are linked to familial phaeochromocytoma. Testing for SDHD mutations is recommended for individuals with familial, multiple, or early-onset phaeochromocytomas.
Area of Science:
- Endocrinology
- Genetics
- Oncology
Background:
- Familial phaeochromocytoma genetics remain largely unknown.
- Familial head and neck paraganglioma is linked to succinate dehydrogenase complex subunit D (SDHD) gene mutations.
- Investigating SDHD in familial phaeochromocytoma kindreds is warranted.
Discussion:
- A germline SDHD frameshift mutation was identified in a family with multiple affected individuals.
- Somatic mutations in SDHD were not found in sporadic phaeochromocytoma tumors.
- This suggests germline SDHD mutations are a cause of familial phaeochromocytoma.
Key Insights:
- Germline SDHD mutations are implicated in familial phaeochromocytoma.
- Early-onset and familial phaeochromocytoma cases should undergo SDHD mutation analysis.
- SDHD testing is valuable even without a history of head and neck paraganglioma.
Outlook:
- Further research into SDHD's role in phaeochromocytoma pathogenesis.
- Development of targeted therapies based on SDHD mutation status.
- Improved genetic screening protocols for at-risk populations.
Related Concept Videos
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...


